Eupraxia Pharmaceuticals
Victoria
About Eupraxia Pharmaceuticals
Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs. Eupraxia's product candidates have the potential to address therapeutic areas with high unmet medical needs and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $246.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: tsx:EPRX
- Website: eupraxiapharma.com
- Phone: 604-558-0920
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/eupraxia-pharmaceuticals-57599 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.